Medicare Enrolled
Dr. Hing-Sheung Fung, MD
Rheumatology · Waco, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fung?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fung
Dr. Hing-Sheung Fung is a rheumatology specialist in Waco, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fung performed 216,008 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fung received a total of $331,793 from 62 pharmaceutical and/or device companies across 1723 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fung is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in TX
$331,793 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗216,008
Medicare services
Top 3% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 86,340 | $5 | $13 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
47,200 | $4 | $13 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
24,002 | $9 | $30 |
| Romosozumab injection (Evenity) for osteoporosis | 22,470 | $8 | $30 |
| Denosumab injection (Prolia/Xgeva) | 15,840 | $18 | $53 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
8,350 | $32 | $101 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
4,450 | $45 | $129 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
4,070 | $26 | $89 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
709 | $52 | $189 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
674 | $87 | $270 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
630 | $94 | $345 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
360 | $1 | $15 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
239 | $20 | $110 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $55 | $184 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
108 | $12 | $85 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
92 | $4 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $116 | $414 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
61 | $37 | $104 |
| Injection, methylprednisolone acetate, 40 mg | 48 | $5 | $30 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
46 | $48 | $187 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
25 | $45 | $156 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
23 | $35 | $154 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
22 | $47 | $270 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
19 | $8 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $114 | $364 |
| New patient office visit, complex (60-74 min) | 15 | $137 | $521 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
17.2% high complexity
82.4% medium
0.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$331,793
Total received (2018-2024)
Avg $47,399/year across 7 years
Top 3% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
1,723
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$33,261
2023
$28,510
2022
$58,444
2021
$29,246
2020
$34,759
2019
$60,108
2018
$87,465
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$16,522
Amgen Inc.
$13,054
Janssen Biotech, Inc.
$579
UCB, Inc.
$390
ABBVIE INC.
$385
Novartis Pharmaceuticals Corporation
$316
Aurinia Pharma U.S., Inc.
$304
Boehringer Ingelheim Pharmaceuticals, Inc.
$273
Mallinckrodt Hospital Products Inc.
$242
ANI Pharmaceuticals, Inc.
$226
Lilly USA, LLC
$180
E.R. Squibb & Sons, L.L.C.
$172
GlaxoSmithKline, LLC.
$153
PFIZER INC.
$137
Octapharma USA, Inc.
$96
Radius Health, Inc.
$66
Fresenius Kabi USA, LLC
$48
Kiniksa Pharmaceuticals International, plc
$30
HOSPIRA, INC.
$28
Sandoz Inc.
$18
Alexion Pharmaceuticals, Inc.
$15
Genentech USA, Inc.
$15
Organon Llc
$11
Top 3 companies account for 90.7% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$79,546
Horizon Therapeutics plc
$59,588
AstraZeneca Pharmaceuticals LP
$49,095
AbbVie, Inc.
$31,545
Horizon Pharma plc
$25,809
Amgen Inc.
$16,612
ABBVIE INC.
$12,095
AbbVie Inc.
$10,824
Janssen Biotech, Inc.
$9,503
Ironwood Pharmaceuticals, Inc
$9,132
Aurinia Pharma U.S., Inc.
$6,193
UCB, Inc.
$3,623
Octapharma USA, Inc.
$2,796
E.R. Squibb & Sons, L.L.C.
$2,192
UCB Biosciences Inc.
$1,755
PFIZER INC.
$1,579
Novartis Pharmaceuticals Corporation
$1,502
Mallinckrodt Hospital Products Inc.
$1,349
GENZYME CORPORATION
$843
Boehringer Ingelheim Pharmaceuticals, Inc.
$712
Radius Health, Inc.
$680
Janssen Scientific Affairs, LLC
$647
GlaxoSmithKline, LLC.
$628
Genentech USA, Inc.
$383
ZOLL Medical Corporation
$367
Mallinckrodt LLC
$350
ANI Pharmaceuticals, Inc.
$328
Celgene Corporation
$305
Gilead Sciences, Inc.
$284
Mallinckrodt Enterprises LLC
$199
SANOFI-AVENTIS U.S. LLC
$170
Genentech, Inc.
$170
Alexion Pharmaceuticals, Inc.
$142
ARBOR PHARMACEUTICALS, INC.
$80
SI-BONE, Inc.
$63
Sandoz Inc.
$54
Fresenius Kabi USA, LLC
$48
Eisai Inc.
$46
Ultragenyx Pharmaceutical Inc.
$46
AltaThera Pharmaceuticals LLC
$40
Antares Pharma, Inc.
$38
Exeltis, USA Inc.
$34
Kiniksa Pharmaceuticals International, plc
$30
Bioventus LLC
$29
Organon LLC
$29
Flexion Therapeutics, Inc.
$28
MEDAC PHARMA, INC.
$28
HOSPIRA, INC.
$28
Kiniksa Pharmaceuticals, Ltd.
$23
Averitas Pharma Inc.
$20
Sobi, Inc
$19
GRT US Holding, Inc.
$18
TerSera Therapeutics LLC
$17
DePuy Synthes Sales Inc.
$16
ADAPT PHARMA INC.
$16
Celltrion USA Inc.
$16
Biogen, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
SOBI, INC
$13
Teva Pharmaceuticals USA, Inc.
$13
Avanos Medical
$13
Organon Llc
$11
Top 3 companies account for 56.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · CHANTIX · COSENTYX · CYLTEZO · Cimzia · Cryvista · DUZALLO · Dayvigo · Durolane · EUCRISA · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Horizant · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Naloxone · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · QUTENZA · Qutenza · Quzyttir · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · Sotalol Hydrochloride · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · TRIVISC SODIUM HYALURONATE · Tavneos · Truxima · Tymlos · ULTOMIRIS · UPLIZNA · Uloric · Ultomiris · XELJANZ · YUFLYMA · Zilretta · iFuse Implant
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
1
County median income
$63,888
Nearest hospital to ZIP centroid (approximate)
ASCENSION PROVIDENCE
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fung is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fung experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Fung performed 86,340 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fung receive payments from pharmaceutical companies?
Yes. Dr. Fung received a total of $331,793 from 62 companies across 1,723 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fung's costs compare to other rheumatologists in Waco?
Dr. Fung's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Waco
Browse rheumatologists in Waco ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology